title: The nuances of NO synthase regulation in sepsis: Could targeting BH4 be the answer?
authors.affiliation: William Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom.
authors.forename: Claire A
authors.initials: CA
authors.lastname: Sand
authors.affiliation: William Harvey Research Institute, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom.
authors.forename: Adrian J
authors.initials: AJ
authors.lastname: Hobbs
mesh_terms: D000818:Animals; D001708:Biopterins / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors / Q000378:metabolism; D004730:Endothelium, Vascular / Q000187:drug effects / Q000201:enzymology / Q000503:physiopathology; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D007022:Hypotension / Q000201:enzymology / Q000503:physiopathology / Q000517:prevention & control; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D018805:Sepsis / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology; D019323:omega-N-Methylarginine / Q000627:therapeutic use
chemical_list: D004791:Enzyme Inhibitors; D001708:Biopterins; D019323:omega-N-Methylarginine; D019001:Nitric Oxide Synthase; C003402:sapropterin